Magnify Ventures closed a $46.6 million second fund, securing backing from Melinda French Gates' Pivotal Ventures alongside other limited partners. The early-stage venture firm focuses on backing founders building solutions across healthcare, education, and economic opportunity.
Pivotal Ventures, Gates' investment vehicle established after her divorce settlement, has increasingly deployed capital into venture-backed startups. The firm backs founders solving systemic problems, particularly in underserved markets. This check signals Gates' confidence in Magnify's thesis and track record from Fund I.
Magnify Ventures operates as an early-stage generalist firm with a bent toward impact investing. Fund II will deploy capital into seed and Series A rounds, targeting entrepreneurs building defensible businesses in verticals where founders can unlock both returns and social value. The firm's LPs span institutional investors, foundations, and family offices aligned with impact-driven venture.
The $46.6 million raise comes as early-stage venture capital faces headwinds. Seed funding declined through 2023 and early 2024 as mega-funds and established players shifted upmarket. Smaller, thesis-driven vehicles like Magnify compete for founder attention by offering pattern recognition, operational support, and network access beyond just capital. Pivotal Ventures' participation adds credibility and potential deal flow access.
Melinda French Gates has emerged as a major venture player in her own right post-Gates Foundation. Pivotal Ventures backed Workable, the Irish HR software platform, and has invested across biotech, fintech, and climate tech. Her backing of Magnify Fund II underscores a strategic pivot toward earlier-stage opportunities and founder support outside traditional Silicon Valley networks.